Echo IQ is trading 5.56% higher at A$0.57, with no specific cause identified.
- The move follows several volatile sessions, including a 31.36% gain on September 18 and subsequent declines.
- Available announcement listings and news results show no new company-specific catalyst for September 29.
- The September 17 update concerned work to address FDA feedback; there is no clear evidence linking it to this session’s rise.